Evidence map›Paper›PMID 8789396›Full record

ReviewThe Histochemical journal1995

Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

F Dolbeare

Abstract readReview
PubMed
In one paragraph

Review in The Histochemical journal, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Amyloid-β immunization enhances neurogenesis and cognitive ability in neonatal mice.International journal of clinical and experimental medicine · 2015
    Article
  3. Article
  4. Abeta immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2009
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

F DolbeareBiology and Biotechnology Program, Lawrence Livermore National Laboratory, University of California 94551-9900, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper follows on from Part 1 of my review of bromodeoxyuridine published earlier this year (Dolbeare, 1995).

Indexed as

Antimetabolites, AntineoplasticBromodeoxyuridineAnimalsCarcinogensHistocytochemistryHumansNeoplasmsAntimetabolites, AntineoplasticBromodeoxyuridineCarcinogens

Identifiers

PMID8789396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.